GSK.L closes below its opening price unable to hold early session gains

GlaxoSmithKline (GSK.L) Technical Analysis Report for Jul 13, 2018 | by Techniquant Editorial Team


GSK.L closes below its opening price unable to hold early session gains
GSK.L unable to break through key resistance level
GSK.L ends the day on a bearish note closing near the low of the day
GSK.L closes within previous day's range after lackluster session


GSK.L ended the week 1.82% higher at 1576.00 after edging lower £0.60 (-0.04%) today. Trading £12.20 higher after the open, the market was unable to hold its gains as the bears took control ending the day below its opening price. Closing within the prior day's range, prices failed to decisively move past the previous day's trading range in a lackluster session. Ending with a weak close near the low of the day sets a bearish note for the next session.

Daily Candlestick Chart (GSK.L as at Jul 13, 2018):

Daily technical analysis candlestick chart for GlaxoSmithKline (GSK.L) as at Jul 13, 2018

Friday's trading range was £17.20 (1.09%), that's below last trading month's daily average range of £22.67. Things look different on a weekly scale, where volatility is slightly below the markets average with the monthly volatility being slightly above average.

Prices are trading close to a key support level at 1572.00. Unable to break through the key technical resistance level at 1590.00, the stock closed below it after spiking as high as 1592.20 during the day. The failure to close above the resistance might increase that levels importance as resistance going forward.

The trend is clearly bullish, showing an intact uptrend in the short, medium and long-term.

Market Conditions for GSK.L as at Jul 13, 2018

Loading Market Conditions for GSK.L (GlaxoSmithKline)...
Trending Assets

Upgrade your trading!

Get the stats behind the charts

Find out what happened when GlaxoSmithKline traded like this in the past. See the odds for each technical pattern with expected gain and loss.

Find out more
Top Movers
You have free reports remaining. Subscribe for unlimited access...SUBSCRIBELOGINGO!